Weili Jin

404 total citations
9 papers, 350 citations indexed

About

Weili Jin is a scholar working on Molecular Biology, Epidemiology and Hepatology. According to data from OpenAlex, Weili Jin has authored 9 papers receiving a total of 350 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Epidemiology and 3 papers in Hepatology. Recurrent topics in Weili Jin's work include Hepatitis B Virus Studies (2 papers), Hepatitis C virus research (2 papers) and Cell Adhesion Molecules Research (2 papers). Weili Jin is often cited by papers focused on Hepatitis B Virus Studies (2 papers), Hepatitis C virus research (2 papers) and Cell Adhesion Molecules Research (2 papers). Weili Jin collaborates with scholars based in China and United States. Weili Jin's co-authors include Carl Nathan, M. Fuortes, Xiaowu Chen, Stephanie A. Leavitt, Neil Squires, Tiffany Barnes, Xiaohong Liu, William J. Watkins, E.B. Lansdon and M. Balakrishnan and has published in prestigious journals such as The Journal of Cell Biology, Scientific Reports and Journal of Medicinal Chemistry.

In The Last Decade

Weili Jin

9 papers receiving 347 citations

Peers

Weili Jin

IA

MB

IMMUN

ID

VIROL

Christophe Kreis Canada

James L. Mobley United States

Geo Derimanov United States

Rodrigo O. de Castro Brazil

Gunther Zischinsky Germany

Emma McKenzie United Kingdom

Florent Colomb United Kingdom

Greg Henkel United States

Pauline M.L. Rood Netherlands

TA Rado United States

Christophe Kreis Canada

Weili Jin

51 ×0.3

IA

175 ×1.2

MB

162 ×1.3

IMMUN

49 ×0.6

ID

101 ×1.9

VIROL

Citations per year, relative to Weili Jin Weili Jin (= 1×) peers Christophe Kreis

Countries citing papers authored by Weili Jin

Since Specialization

Citations

This map shows the geographic impact of Weili Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weili Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weili Jin more than expected).

Fields of papers citing papers by Weili Jin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weili Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weili Jin. The network helps show where Weili Jin may publish in the future.

Co-authorship network of co-authors of Weili Jin

This figure shows the co-authorship network connecting the top 25 collaborators of Weili Jin. A scholar is included among the top collaborators of Weili Jin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weili Jin. Weili Jin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Jin, Weili, Haojun Chen, Linfeng Wang, et al.. (2024). Assessing peptic ulcer risk with the HAMPROW score in the general Chinese population. Scientific Reports. 14(1). 4442–4442. 2 indexed citations

2.

Zhang, Hong, Lei Gao, Min Wu, et al.. (2022). First-In-Human Study on Pharmacokinetics, Safety, and Tolerability of Single and Multiple Escalating Doses of Hepenofovir, a Novel Hepatic Targeting Prodrug of Tenofovir in Healthy Chinese Subjects. Frontiers in Pharmacology. 13. 873588–873588. 3 indexed citations

3.

Jin, Weili, et al.. (2022). Endoscopic Therapy of Small Bowel Polyps by Single‐Balloon Enteroscopy in Patients with Peutz–Jeghers Syndrome. International Journal of Clinical Practice. 2022(1). 7849055–7849055. 5 indexed citations

4.

Li, Qian, et al.. (2021). High expression of PPM1G is associated with the progression and poor prognosis of hepatocellular carcinoma. Cancer Biomarkers. 34(1). 13–22. 4 indexed citations

5.

Zhang, Hong, Min Wu, Xiaoxue Zhu, et al.. (2019). Safety, efficacy, and pharmacokinetics of pradefovir for the treatment of chronic hepatitis B infection. Antiviral Research. 174. 104693–104693. 14 indexed citations

6.

Jin, Weili, et al.. (2015). c-Met and RON expression levels in endometrial adenocarcinoma tissue and their relationship with prognosis.. PubMed. 36(3). 255–9. 10 indexed citations

7.

Kirschberg, Thorsten, M. Balakrishnan, Neil Squires, et al.. (2009). RNase H Active Site Inhibitors of Human Immunodeficiency Virus Type 1 Reverse Transcriptase: Design, Biochemical Activity, and Structural Information. Journal of Medicinal Chemistry. 52(19). 5781–5784. 86 indexed citations

8.

Fuortes, M., Weili Jin, & Carl Nathan. (1994). Beta 2 integrin-dependent tyrosine phosphorylation of paxillin in human neutrophils treated with tumor necrosis factor.. The Journal of Cell Biology. 127(5). 1477–1483. 91 indexed citations

9.

Fuortes, M., Weili Jin, & Carl Nathan. (1993). Adhesion-dependent protein tyrosine phosphorylation in neutrophils treated with tumor necrosis factor.. The Journal of Cell Biology. 120(3). 777–784. 135 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact